NASDAQ:SNMX Senomyx (SNMX) Stock Price, News & Analysis → Make This $3 Trade the Instant the Opening Bell Rings (From Monument Traders Alliance) (Ad) Free SNMX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$1.49▼$1.4950-Day Range N/A52-Week Range$0.83▼$1.71VolumeN/AAverage Volume151,720 shsMarket Capitalization$72.03 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Senomyx alerts: Email Address Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now About Senomyx Stock (NASDAQ:SNMX)Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries in the United States. The company develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It sells various flavor ingredients directly to flavor companies. The company has collaboration agreements with Ajinomoto Co., Inc.; Firmenich SA; and PepsiCo, Inc. Senomyx, Inc. was founded in 1998 and is headquartered in San Diego, California.Read More Ad Crypto 101 MediaLike Tiny Crypto Retirement FundsThe crypto bull market is about to blast off. Bitcoin and Ethereum are surging. But so are tiny altcoins that could be so profitable… They're like tiny crypto retirement funds. Click here and see how to get a copy. SNMX Stock News HeadlinesDecember 9, 2023 | morningstar.comAKD Securities Ltd Ordinary Shares AKDSLJuly 19, 2023 | investing.comNZ Automotive Investments Ltd (NZA)March 18, 2024 | Behind the Markets (Ad)The only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.March 30, 2023 | thestreet.comMcKesson Inc. (MCK): Today's Featured Wholesale LaggardFebruary 23, 2023 | usatoday.comFact check: Fetal tissue not in your food, drinks, experts sayJune 2, 2022 | thestreet.comHow to Get Stock Exposure to Gluten-Free MovementJanuary 29, 2022 | fool.comSenomyx, Inc.(SNMX)See More Headlines Receive SNMX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Senomyx and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/02/2018Today3/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:SNMX CUSIPN/A CIK1123979 Webwww.senomyx.com Phone858-646-8300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,260,000.00 Net Margins-9.11% Pretax MarginN/A Return on Equity-15.80% Return on Assets-10.48% Debt Debt-to-Equity RatioN/A Current Ratio4.35 Quick Ratio3.92 Sales & Book Value Annual Sales$29.32 million Price / Sales2.46 Cash FlowN/A Price / Cash FlowN/A Book Value$0.39 per share Price / Book3.82Miscellaneous Outstanding Shares48,340,000Free FloatN/AMarket Cap$72.03 million OptionableOptionable Beta1.33 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. John W. Poyhonen (Age 58)Pres, CEO & Director Mr. David C. Humphrey (Age 49)VP & CFO Ms. Catherine C. Lee (Age 44)Sr. VP, Gen. Counsel & Corp. Sec. Ms. Sharon Wicker (Age 62)Sr. VP & Chief Commercial Devel. Officer Ms. Susan Firestone MelodyVP of HRKey CompetitorsGrove CollaborativeNYSE:GROVLee EnterprisesNYSE:LEEVillage Farms InternationalNASDAQ:VFFMoolec ScienceNASDAQ:MLECVirgin Group Acquisition Corp. IINYSE:VGIIView All Competitors SNMX Stock Analysis - Frequently Asked Questions How were Senomyx's earnings last quarter? Senomyx, Inc. (NASDAQ:SNMX) posted its earnings results on Thursday, August, 2nd. The specialty chemicals company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.09) by $0.01. The specialty chemicals company had revenue of $3.29 million for the quarter. Senomyx had a negative net margin of 9.11% and a negative trailing twelve-month return on equity of 15.80%. What other stocks do shareholders of Senomyx own? Based on aggregate information from My MarketBeat watchlists, some companies that other Senomyx investors own include Aralez Pharmaceuticals (ARLZ), Heron Therapeutics (HRTX), Novavax (NVAX), Rexahn Pharmaceuticals (REXN), Vical (VICL), (CASC) (CASC), DURECT (DRRX), Idera Pharmaceuticals (IDRA), Inovio Pharmaceuticals (INO) and Lexicon Pharmaceuticals (LXRX). This page (NASDAQ:SNMX) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingBill Gates Bets on $15 Trillion BonanzaWeiss RatingsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Senomyx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.